{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:45:47Z","timestamp":1785897947107,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08256-1","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:04:06Z","timestamp":1778745846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting mitochondrial calcium homeostasis via novel S100A9 inhibitor B2 as a promising agent against AML"],"prefix":"10.1186","volume":"24","author":[{"given":"Chujiao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renguang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8595-5062","authenticated-orcid":false,"given":"Shi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"S2","key":"8256_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/ajh.27584","volume":"Suppl 100","author":"CG Moore","year":"2025","unstructured":"Moore CG, Stein A, Fathi AT, Pullarkat V. Treatment of relapsed\/refractory AML \u2014novel treatment options including immunotherapy. Am J Hematol. 2025;Suppl 100(S2):23\u201337. https:\/\/doi.org\/10.1002\/ajh.27584.","journal-title":"Am J Hematol"},{"issue":"1","key":"8256_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13045-024-01617-7","volume":"17","author":"J Cortes","year":"2024","unstructured":"Cortes J. Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD\u2013positive AML. J Hematol Oncol. 2024;17(1):111. https:\/\/doi.org\/10.1186\/s13045-024-01617-7.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"8256_CR3","doi-asserted-by":"publisher","first-page":"104367","DOI":"10.1016\/j.drudis.2025.104367","volume":"30","author":"QY Rong","year":"2025","unstructured":"Rong QY, Lu Y, Zhang W, Rao GW, Zheng Q. Targeting FLT3 for treating diseases: FLT3 inhibitors. Drug Discov Today. 2025;30(5):104367. https:\/\/doi.org\/10.1016\/j.drudis.2025.104367.","journal-title":"Drug Discov. Today Today"},{"issue":"1","key":"8256_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","volume":"14","author":"H Kantarjian","year":"2024","unstructured":"Kantarjian H, Borthakur G, Daver N, DiNardo CD, Issa G, Jabbour E, et al. Current status and research directions in acute myeloid leukemia. Blood Cancer J. 2024;14(1):163. https:\/\/doi.org\/10.1038\/s41408-024-01143-2.","journal-title":"Blood Cancer J"},{"issue":"12","key":"8256_CR5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.17219\/acem\/181145","volume":"33","author":"K Zielonka","year":"2024","unstructured":"Zielonka K, Jamroziak K. Mechanisms of resistance to venetoclax in hematologic malignancies. Adv Clin Exp Med. 2024;33(12):1421\u201333. https:\/\/doi.org\/10.17219\/acem\/181145.","journal-title":"Adv Clin Exp Med"},{"key":"8256_CR6","doi-asserted-by":"publisher","unstructured":"Sullivan GP, Flanagan L, Rodrigues DA, N\u00ed Chonghaile T. The path to venetoclax resistance is paved with mutations, metabolism, and more. Sci Transl Med. 2022;14(674):eabo 6891. https:\/\/doi.org\/10.1126\/scitranslmed.abo6891.","DOI":"10.1126\/scitranslmed.abo6891"},{"issue":"5","key":"8256_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","volume":"45","author":"M Forsberg","year":"2024","unstructured":"Forsberg M, Konopleva M. AML treatment: conventional chemotherapy and emerging novel agents. Trends Pharmacol Sci. 2024;45(5):430\u201348. https:\/\/doi.org\/10.1016\/j.tips.2024.03.005.","journal-title":"Trends Pharmacological Sci"},{"issue":"1","key":"8256_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29. https:\/\/doi.org\/10.1186\/s13045-023-01424-6.","journal-title":"J Hematol Oncol"},{"key":"8256_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/bs.ircmb.2021.05.003","volume":"362","author":"M Bonora","year":"2021","unstructured":"Bonora M, Kahsay A, Pinton P. Mitochondrial calcium homeostasis in hematopoietic stem cell: molecular regulation of quiescence, function, and differentiation. Int Rev Cell Mol Biol. 2021;362:111\u201340.","journal-title":"Int Rev Cell Mol Biol"},{"issue":"4","key":"8256_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.stem.2025.01.013","volume":"32","author":"Z Song","year":"2025","unstructured":"Song Z, Cui Y, Xin L, Xiao R, Feng J, Li C, et al. Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation. Cell Stem Cell. 2025;32(4):581\u201397.e11. https:\/\/doi.org\/10.1016\/j.stem.2025.01.013.","journal-title":"Cell STEM Cell"},{"issue":"3","key":"8256_CR11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1152\/physrev.00034.2023","volume":"105","author":"D Kracun","year":"2025","unstructured":"Kracun D, Lopes LR, Cifuentes-Pagano E, Pagano PJ. NADPH oxidases: redox regulation of cell homeostasis and disease. Physiol Rev. 2025;105(3):1291\u2013428. https:\/\/doi.org\/10.1152\/physrev.00034.2023.","journal-title":"Physiol Rev"},{"key":"8256_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.actbio.2025.06.009","volume":"201","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Ling K, Yan J, Wang Z, Chen C, Sun D, et al. Nano-carriers mediate reciprocally chained promotion between ROS and mitochondrial calcium overload for enhanced antitumor therapy. Acta Biomater. 2025;201:545\u201358. https:\/\/doi.org\/10.1016\/j.actbio.2025.06.009.","journal-title":"Acta Biomater"},{"issue":"12","key":"8256_CR13","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1038\/s44318-025-00454-9","volume":"44","author":"FE Oflaz","year":"2025","unstructured":"Oflaz FE, Bondarenko AI, Trenker M, Waldeck-Weiermair M, Gottschalk B, Bernhart E, et al. Annexin A5 controls VDAC1-dependent mitochondrial Ca2+ homeostasis and determines cellular susceptibility to apoptosis. EMBO J. 2025;44(12):3413\u201347. https:\/\/doi.org\/10.1038\/s44318-025-00454-9.","journal-title":"Embo J"},{"issue":"10","key":"8256_CR14","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1158\/2159-8290.CD-23-1145","volume":"14","author":"AI Sheth","year":"2024","unstructured":"Sheth AI, Althoff MJ, Tolison H, Engel K, Amaya ML, Krug AE, et al. Targeting acute myeloid leukemia stem cells through perturbation of mitochondrial calcium. Cancer Discov. 2024;14(10):1922\u201339. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1145.","journal-title":"Cancer Discov"},{"key":"8256_CR15","doi-asserted-by":"crossref","unstructured":"Lewuillon C, Laguillaumie MO, Quesnel B, Idziorek T, Touil Y, Lemonnier L. Put in a \u201cCa(2+)ll\u201d to acute myeloid leukemia. Cells. 2022;11.","DOI":"10.3390\/cells11030543"},{"issue":"14","key":"8256_CR16","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood-2016-09-738005","volume":"129","author":"M Laouedj","year":"2017","unstructured":"Laouedj M, Tardif MR, Gil L, Raquil MA, Lachhab A, Pelletier M, et al. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4. Blood. 2017;129(14):1980\u201390. https:\/\/doi.org\/10.1182\/blood-2016-09-738005.","journal-title":"Blood"},{"issue":"3","key":"8256_CR17","doi-asserted-by":"publisher","first-page":"188891","DOI":"10.1016\/j.bbcan.2023.188891","volume":"1878","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ouyang Y, Li Z, Wang X, Ma J. S100A8 and S100A9 in Cancer. Biochim Et Biophys Acta (BBA) - Rev Cancer. 2023;1878(3):188891. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188891.","journal-title":"Biochim Et Biophys Acta (BBA) - Rev Cancer"},{"key":"8256_CR18","doi-asserted-by":"publisher","unstructured":"Zhong C, Niu Y, Liu W, Yuan Y, Li K, Shi Y, et al. S100A9 derived from chemoembolization-induced hypoxia governs mitochondrial function in hepatocellular carcinoma progression. Adv Sci. 2022;9(30):e2202206. https:\/\/doi.org\/10.1002\/advs.202202206.","DOI":"10.1002\/advs.202202206"},{"issue":"1","key":"8256_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41408-023-00962-z","volume":"13","author":"R Fan","year":"2023","unstructured":"Fan R, Satilmis H, Vandewalle N, Verheye E, De Bruyne E, Menu E, et al. Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in acute myeloid leukemia. Blood Cancer J. 2023;13(1):188. https:\/\/doi.org\/10.1038\/s41408-023-00962-z.","journal-title":"Blood Cancer J"},{"issue":"17","key":"8256_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms241713382","volume":"24","author":"F Razmkhah","year":"2023","unstructured":"Razmkhah F, Kim S, Lim S, Dania AJ, Choi J. S100A8 and S100A9 in hematologic malignancies: from development to therapy. Int J Mol Sci. 2023;24(17):24. https:\/\/doi.org\/10.3390\/ijms241713382.","journal-title":"IJMS"},{"issue":"23","key":"8256_CR21","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1182\/bloodadvances.2021005614","volume":"5","author":"ME Zavorka Thomas","year":"2021","unstructured":"Zavorka Thomas ME, Jeon JY, Talebi Z, Buelow DR, Silvaroli J, Campbell MJ, et al. Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia. Blood Adv. 2021;5(23):5041\u201346. https:\/\/doi.org\/10.1182\/bloodadvances.2021005614.","journal-title":"Blood Adv"},{"issue":"5","key":"8256_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/molecules26051323","volume":"26","author":"J Mondet","year":"2021","unstructured":"Mondet J, Chevalier S, Mossuz P. Pathogenic Roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts. Molecules. 2021;26(5):26. https:\/\/doi.org\/10.3390\/molecules26051323.","journal-title":"Molecules"},{"issue":"3","key":"8256_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s11596-025-00042-2","volume":"45","author":"XY Cai","year":"2025","unstructured":"Cai XY, Huang GQ, Zhou YM, Li DJ. Targeting calprotectin S100A8\/A9 to overcome AML progression in DNMT3A-Mutant cells. Curr Med Sci. 2025;45(3):458\u201368. https:\/\/doi.org\/10.1007\/s11596-025-00042-2.","journal-title":"Curr Med Sci"},{"issue":"21","key":"8256_CR24","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.1182\/bloodadvances.2021005938","volume":"6","author":"M Bottcher","year":"2022","unstructured":"Bottcher M, Panagiotidis K, Bruns H, Stumpf M, Volkl S, Geyh S, et al. Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8\/A9high AML cell subset. Blood Adv. 2022;6(21):5685\u201397. https:\/\/doi.org\/10.1182\/bloodadvances.2021005938.","journal-title":"Blood Adv"},{"issue":"11","key":"8256_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers17111781","volume":"17","author":"AE Temple","year":"2025","unstructured":"Temple AE, Walker SR. The Roles of STAT3 and STAT5 in breast cancer. Cancers (Basel). 2025;17(11):17. https:\/\/doi.org\/10.3390\/cancers17111781.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"8256_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","volume":"23","author":"YJ Li","year":"2023","unstructured":"Li YJ, Zhang C, Martincuks A, Herrmann A, Yu H. STAT proteins in cancer: orchestration of metabolism. Nat Rev Cancer. 2023;23(3):115\u201334. https:\/\/doi.org\/10.1038\/s41568-022-00537-3.","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08256-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08256-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08256-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:02:45Z","timestamp":1785895365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08256-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8256"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08256-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7531512\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University (Approval No. 2021483). Written informed consent was obtained from all participants or their legal guardians prior to the study. All animal procedures were performed in strict adherence to the ARRIVE guidelines 2.0. The experimental protocol was approved by the Animal Ethics Committee of Guizhou Medical University (Institutional Animal Care and Use Committee, IACUC; Approval No. 2101287).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final manuscript and consent to publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"997"}}